|Day Low/High||34.24 / 34.81|
|52 Wk Low/High||32.33 / 41.55|
The Dutch molecular diagnostic company will pay $1.6 billion for its U.S. rival.
Don't make long-term commitments on either side of the market ahead of the FOMC meeting.
A very busy JPMorgan Healthcare Conference offers up some with good news and others in denial.
The prize awarded to two RNAi researchers is likely good for investor confidence in the sector.
Cramer believes the stock is headed to $100.
ING's Internet unit is driving growth at the Dutch financial services company, and the stock's likely to head higher.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.